TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25602493

Group type: EXPERIMENTAL
Intervention: 35-min hazard perception training intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 75
Study: 22864680

Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia
Number of subjects: 64

Group type: COMPARATOR
Intervention: Low load stretch (stretch)
Number of subjects: 64
Study: 21678186

Group type: EXPERIMENTAL
Intervention: Campus bar context
Number of subjects: 383

Group type: COMPARATOR
Intervention: Library context
Number of subjects: 383
Study: 18987553

Group type: EXPERIMENTAL
Intervention: Pyridostygmine (60 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Buspirone (20 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bethanechol (25 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All three agents (Pyridostygmine, Buspirone, Bethanechol)
Number of subjects: 10
Study: 16820420

Group type: EXPERIMENTAL
Intervention: Interactive multimedia internet‐based system (IMIS) + integrated psychostimulation program (IPP)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Integrated psychostimulation program (IPP)
Number of subjects: 46

Group type: COMPARATOR
Intervention: ChEI treatment
Number of subjects: 46
Study: 12149529

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 2 x 500 microg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 10102256

Group type: EXPERIMENTAL
Intervention: Sibutramine 1 mg/day
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Sibutramine 5 mg/day
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg/day
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg/day
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Sibutramine 20 mg/day
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Sibutramine 30 mg/day
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1047
Study: 8589555

Group type: COMPARATOR
Intervention: Plasmatein (10%, v/v; 5 mg/ml)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lot 1 of SSS (HSA 84% and human globulins 16%)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lot 1 of SSS
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lipoprotein free SSS
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lot 3 of SSS
Number of subjects: 7
Study: 2317144

Group type: EXPERIMENTAL
Intervention: Endurance training program (E) - three times weekly upper and lower conditioning program using target heart rates based on the symptom-limited exercise test (SLXT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (C) - continued daily nursing home routine
Number of subjects: 15
Study: 347877

Group type: EXPERIMENTAL
Intervention: Bromperidol (4 to 8 mg in one intake in the morning)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Haloperidol (4 mg given twice a day)
Number of subjects: 24
Study: 6122939

Group type: EXPERIMENTAL
Intervention: 150 ml of 5% dextrose in water (D5W) and 1000 ml normal saline (7.5 g dextrose)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 150 ml of D5W, 350 ml of 5% dextrose in normal saline (D5NS), and 650 ml of normal saline (25 g dextrose)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 150 ml D5W and 1000 ml D5NS (57.5 g dextrose)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 57.5 g of dextrose
Number of subjects: 47

Group type: COMPARATOR
Intervention: 7.5 g dextrose
Number of subjects: 47
Study: 31054219

Group type: EXPERIMENTAL
Intervention: 12 weeks of supervised exercise intervention
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Rectus femoris CSA measurement
Number of subjects: 36
Study: 29402228

Group type: EXPERIMENTAL
Intervention: Extended nutritional intervention
Number of subjects: 148

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 148
Study: 27918630

Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation (RAS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional gait training (Control)
Number of subjects: 12
Study: 24830759

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided vascular access
Number of subjects: 95

Group type: COMPARATOR
Intervention: Landmark-guided vascular access
Number of subjects: 95
Study: 22753637

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Improvement in depression
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Higher socioeconomic status
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Fewer comorbid conditions
Number of subjects: 274
Study: 20705512

Group type: EXPERIMENTAL
Intervention: Rheohaemapheresis
Number of subjects: 0
Study: 17681972

Group type: EXPERIMENTAL
Intervention: Liberal fluid administration (median 5050 ml, range 3563-8050 ml)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Restrictive fluid administration (median 1640 ml, range 935-2250 ml)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 15533541

Group type: EXPERIMENTAL
Intervention: High intensity intervention group
Number of subjects: 2408

Group type: COMPARATOR
Intervention: Low intensity intervention group
Number of subjects: 2408

Group type: COMPARATOR
Intervention: Background population
Number of subjects: 2408
Study: 11834770

Group type: EXPERIMENTAL
Intervention: 400 microg folic acid
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: 600 microg folic acid
Number of subjects: 368

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 368
Study: 10078855

Group type: EXPERIMENTAL
Intervention: VLCD-strict
Number of subjects: 121

Group type: COMPARATOR
Intervention: VLCD-plus
Number of subjects: 121

Group type: COMPARATOR
Intervention: VLCD-mw
Number of subjects: 121
Study: 7667959

Group type: EXPERIMENTAL
Intervention: Experimental diet with topinambur (mashed topinambur 100 g/day and cookies with topinambur 50 g/day for 4 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control diet without topinambur
Number of subjects: 35
Study: 2109195

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms four times daily for 12 weeks)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 7402234

Group type: EXPERIMENTAL
Intervention: Supportive lay woman (doula)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136
Study: 30469103

Group type: EXPERIMENTAL
Intervention: Visual feedback gait retraining
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control no-feedback group
Number of subjects: 25
Study: 29576354

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE) 3.6 g daily for 6 weeks
Number of subjects: 51
Study: 26871905

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate tocolysis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 30
Study: 25108611

Group type: EXPERIMENTAL
Intervention: Ecological intervention program promoting healthy lifestyle behaviors
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nutrition domain strategies
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Physical Activity domain strategies
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Use of Reciprocal Determinism as SCT construct
Number of subjects: 15
Study: 23025957

Group type: EXPERIMENTAL
Intervention: Simulator training (30-minute session)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Didactic lecture (30-minute session)
Number of subjects: 24
Study: 19250838

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 17464919

Group type: EXPERIMENTAL
Intervention: Hand sanitizer with 70% isopropyl alcohol and 0.5% chlorhexidine gluconate introduced in ward A
Number of subjects: 786

Group type: COMPARATOR
Intervention: No intervention in ward B
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Hand sanitizer in ward A
Number of subjects: 786
Study: 15024318

Group type: EXPERIMENTAL
Intervention: Breast Cancer Structured Clinical Instruction Module (BCSCIM)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 12005118

Group type: COMPARATOR
Intervention: 0% SLS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.125% SLS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.25% SLS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.50% SLS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.0% SLS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clinical irritation scores on day 3
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mean perfusion
Number of subjects: 12
Study: 9796236

Group type: EXPERIMENTAL
Intervention: Qualitative shape features
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Connection angles (bias towards connection angles)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feature-based model of shape representation
Number of subjects: 0
Study: 7611096

Group type: EXPERIMENTAL
Intervention: Angiopeptin (750 micrograms/day)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Angiopeptin
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 1710742

Group type: EXPERIMENTAL
Intervention: Bezafibrate (Bezalip Mono, 400 mg daily for 3 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 361149

Group type: EXPERIMENTAL
Intervention: Bromocriptine, 5 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31334927

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO), Hyaluronic Acid (HA) filler, and Restylane® Skinboosters (RSB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA) filler alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: AbobotulinumtoxinA (ABO) alone
Number of subjects: 0
Study: 26774526

Group type: EXPERIMENTAL
Intervention: PRO (micellar casein without milk fat)
Number of subjects: 24

Group type: COMPARATOR
Intervention: PRO + FAT (micellar casein with 26.7 g milk fat)
Number of subjects: 24
Study: 26635308

Group type: EXPERIMENTAL
Intervention: 0.1 ppm acrolein
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.05 ppm acrolein
Number of subjects: 18

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 18

Group type: COMPARATOR
Intervention: 15 ppm ethyl acetate (EA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.1 ppm acrolein with 15 ppm EA
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.05 ppm acrolein with 15 ppm EA
Number of subjects: 18

Group type: COMPARATOR
Intervention: Other exposure conditions (0.1 ppm acrolein with EA, 15 ppm EA)
Number of subjects: 18
Study: 23433735

Group type: EXPERIMENTAL
Intervention: Web-based CBT-grounded interventions with e-diaries and personalized feedback
Number of subjects: 0
Study: 21998095

Group type: EXPERIMENTAL
Intervention: Stiff and flexible prosthetic foot (CTA group)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Cyclists with intact limbs
Number of subjects: 17
Study: 18300900

Group type: EXPERIMENTAL
Intervention: External lumbar drainage (ELD) of cerebrospinal fluid (approximately 135 mL/24 h for 3 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (matching controls)
Number of subjects: 18
Study: 17136216

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg) and alcohol (1.0 mL 95% USP ethanol/kg body weight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo and alcohol (1.0 mL 95% USP ethanol/kg body weight)
Number of subjects: 20
Study: 12655280

Group type: EXPERIMENTAL
Intervention: Nurse case management (NURS)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 158
Study: 11015696

Group type: EXPERIMENTAL
Intervention: Umbilical artery pulsatility index (UAPI) in fetuses with enlarged NT
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Umbilical artery pulsatility index (UAPI) in normal karyotype fetuses with enlarged NT
Number of subjects: 121

Group type: COMPARATOR
Intervention: Umbilical artery pulsatility index (UAPI) in normal karyotype fetuses with normal NT
Number of subjects: 121
Study: 8865445

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg bid
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg bid
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control (no treatment mentioned)
Number of subjects: 142
Study: 1475230

Group type: EXPERIMENTAL
Intervention: Enteric-coated 500-mg naproxen tablets (fasted state)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Enteric-coated 500-mg naproxen tablets (after breakfast)
Number of subjects: 7
Study: 6465056

Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol acetate
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol succinate
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol acetate plus apple pectin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: all-rac-alpha-tocopheryl acetate
Number of subjects: 20
Study: 31369662

Group type: EXPERIMENTAL
Intervention: Right dorsolateral prefrontal cortex (DLPFC) inhibitory rTMS
Number of subjects: 61
Study: 29056327

Group type: EXPERIMENTAL
Intervention: Home-dressed scrubs
Number of subjects: 21

Group type: COMPARATOR
Intervention: Hospital-dressed scrubs
Number of subjects: 21
Study: 27806900

Group type: EXPERIMENTAL
Intervention: OCT guidance
Number of subjects: 450

Group type: COMPARATOR
Intervention: IVUS guidance
Number of subjects: 450

Group type: COMPARATOR
Intervention: Angiography guidance
Number of subjects: 450
Study: 25358330

Group type: EXPERIMENTAL
Intervention: 30 mg/kg loading dose of vancomycin
Number of subjects: 99

Group type: COMPARATOR
Intervention: 15 mg/kg traditional dose of vancomycin
Number of subjects: 99
Study: 24617225

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medicine (dicetel and bifidobacterium lactobacillus triple viable capsules)
Number of subjects: 40
Study: 21600128

Group type: EXPERIMENTAL
Intervention: Propofol 3 µg/ml plus remifentanil 2.5 ng/ml
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol 2 µg/ml plus remifentanil 2.0 ng/ml
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol 4 µg/ml plus remifentanil 3.0 ng/ml
Number of subjects: 120
Study: 18655554

Group type: EXPERIMENTAL
Intervention: Astragalus injection (40 mL, 10 mL containing 2 g of crude drug)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no Astragalus injection)
Number of subjects: 30
Study: 17068655

Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 0

Group type: COMPARATOR
Intervention: IntraSite Gel
Number of subjects: 0
Study: 14502007

Group type: EXPERIMENTAL
Intervention: Abacavir, stavudine and didanosine (A/S/D, n = 60)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Ritonavir and saquinavir (R/S, n = 60)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nelfinavir and nevirapine (N/N, n = 60)
Number of subjects: 180
Study: 10918470

Group type: EXPERIMENTAL
Intervention: Red wine (4 glasses, 40 g alcohol/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Beer (4 glasses, 40 g alcohol/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Spirits (4 glasses, 40 g alcohol/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water (negative control)
Number of subjects: 12
Study: 9175953

Group type: EXPERIMENTAL
Intervention: Breastfeeding (group B)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard infant formula (group S)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Infant formula supplemented with nucleotides (group N)
Number of subjects: 3
Study: 8157948

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with enalapril (20-40 mg once a day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with enalapril
Number of subjects: 19
Study: 3145964

Group type: EXPERIMENTAL
Intervention: alpha-interferon
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: gamma-interferon
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: combination of alpha-interferon and gamma-interferon
Number of subjects: 89
Study: 31489639

Group type: EXPERIMENTAL
Intervention: Talazoparib 1 mg capsule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Talazoparib 0.75 mg daily dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Talazoparib (general)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 0
Study: 28900838

Group type: EXPERIMENTAL
Intervention: DJPI (Detoxified Jatropha Protein Isolate)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: S 75 (Soy Protein Isolate, 75% replacement)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: S 50 (Soy Protein Isolate, 50% replacement)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: J 75 (Jatropha Protein Isolate, 75% replacement)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Plant protein-based diets (including DJPI and SPI)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Plant protein-fed groups
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 75
Study: 28446537

Group type: EXPERIMENTAL
Intervention: Aspirin plus clopidogrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin plus placebo
Number of subjects: 0
Study: 26224751

Group type: EXPERIMENTAL
Intervention: Jejunal feeding of intact casein
Number of subjects: 11

Group type: COMPARATOR
Intervention: Gastric feeding
Number of subjects: 11
Study: 24877660

Group type: EXPERIMENTAL
Intervention: 40 g soy flour (whole soy group)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 40 g low-fat milk powder + 63 mg daidzein (daidzein group)
Number of subjects: 270

Group type: COMPARATOR
Intervention: 40 g low-fat milk powder (placebo group)
Number of subjects: 270
Study: 23137600

Group type: EXPERIMENTAL
Intervention: Computer-based simulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kolb's Experiential Learning Theory (ELT)
Number of subjects: 0
Study: 20512414

Group type: EXPERIMENTAL
Intervention: 0.5 mg entecavir daily until October 2009 (group A)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 100 mg lamivudine daily until October 2009 (group B)
Number of subjects: 104

Group type: COMPARATOR
Intervention: No nucleoside analogue (group C)
Number of subjects: 104
Study: 18612729

Group type: EXPERIMENTAL
Intervention: Adaptive web-based learning (WBL) format
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard web-based learning (WBL) format
Number of subjects: 122
Study: 16078322

Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy > 10 mg prednisolone equivalent per day
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Lymphocytopenia < 600/microl
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: T-helper lymphocytopenia < 250/microl
Number of subjects: 97
Study: 11840438

Group type: EXPERIMENTAL
Intervention: leflunomide
Number of subjects: 39

Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 39
Study: 10636369

Group type: EXPERIMENTAL
Intervention: Third-generation oral contraceptive (150 microg desogestrel and 30 microg ethinyloestradiol)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Second-generation oral contraceptive (150 microg levonorgestrel and 30 microg ethinyloestradiol)
Number of subjects: 28
Study: 8936358

Group type: EXPERIMENTAL
Intervention: D-penicillamine (D-P)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Zinc sulphate (Zn)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: D-penicillamine (D-P) and Zinc sulphate (Zn)
Number of subjects: 67
Study: 1555284

Group type: EXPERIMENTAL
Intervention: Intermittent ST depression (STD)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Untreated patients with STD
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Propranolol-treated patients with STD
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo group with 1-30 minutes of STD
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo group with greater than 30 minutes of STD
Number of subjects: 261
Study: 3873108

Group type: EXPERIMENTAL
Intervention: co‐trimoxazole (800 mg sulphamethoxazole + 160 mg trimethoprim)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: trimethoprim (200 mg)
Number of subjects: 24
Study: 31204264

Group type: EXPERIMENTAL
Intervention: Low-Intensity Shockwave Therapy (LiST)
Number of subjects: 138
Study: 29402731

Group type: EXPERIMENTAL
Intervention: Electromagnetic (EM) navigation system for condylar positioning
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard manual replacement
Number of subjects: 20
Study: 27063317

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Muscle relaxation
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Suggestion therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 24885396

Group type: EXPERIMENTAL
Intervention: Tubridge implantation alone or combined with bared coils
Number of subjects: 124

Group type: COMPARATOR
Intervention: Stent‐assisted coiling (bare coils)
Number of subjects: 124
Study: 21885314

Group type: EXPERIMENTAL
Intervention: Birth Ball (BB) intervention during labour
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no Birth Ball)
Number of subjects: 58
Study: 20166411

Group type: EXPERIMENTAL
Intervention: Nano-composite (Filtek Supreme XT-3M ESPE) with two-step self-etch adhesive (Adper SE Plus-3M ESPE)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nano-composite (Filtek Supreme XT-3M ESPE) with etch&rinse adhesive (Adper Single Bond 2-3M ESPE)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flowable nano-composite (Filtek Supreme XT Flow-3M ESPE) with two-step self-etch adhesive (Adper SE Plus-3M ESPE)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flowable nano-composite (Filtek Supreme XT Flow-3M ESPE) with etch&rinse adhesive (Adper Single Bond 2-3M ESPE)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nanofilled resin-modified glass ionomer (Ketac N100-3M ESPE) with Ketac Nano Primer (3M ESPE)
Number of subjects: 60
Study: 17965814

Group type: EXPERIMENTAL
Intervention: Group caregiver education in schizophrenia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90